TrialBMC infectious diseases2016

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.

Jaime Galindo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.